Your browser doesn't support javascript.
loading
Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis.
Yamamoto, Shohei; Matsuda, Kouki; Maeda, Kenji; Horii, Kumi; Okudera, Kaori; Oshiro, Yusuke; Inamura, Natsumi; Nemoto, Takashi; Takeuchi, Junko S; Li, Yunfei; Konishi, Maki; Tsuchiya, Kiyoto; Gatanaga, Hiroyuki; Oka, Shinichi; Mizoue, Tetsuya; Sugiyama, Haruhito; Aoyanagi, Nobuyoshi; Mitsuya, Hiroaki; Sugiura, Wataru; Ohmagari, Norio.
Affiliation
  • Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Matsuda K; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Maeda K; Japan Foundation for AIDS Prevention, Tokyo, Japan.
  • Horii K; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
  • Okudera K; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
  • Oshiro Y; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Inamura N; Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Nemoto T; Infection Control Office, Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan.
  • Takeuchi JS; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Li Y; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Konishi M; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Tsuchiya K; Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Gatanaga H; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Oka S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mizoue T; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sugiyama H; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Aoyanagi N; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mitsuya H; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Sugiura W; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan.
J Infect Dis ; 228(12): 1652-1661, 2023 12 20.
Article de En | MEDLINE | ID: mdl-37756608
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Syndrome de post-COVID-19 Limites: Humans Langue: En Journal: J Infect Dis Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Syndrome de post-COVID-19 Limites: Humans Langue: En Journal: J Infect Dis Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique